Evidence map›Paper›PMID 35073754›Full record

ArticlemBio2022

Interbacterial Transfer of Carbapenem Resistance and Large Antibiotic Resistance Islands by Natural Transformation in Pathogenic Acinetobacter.

Anne-Sophie Godeux, Elin Svedholm, Samuel Barreto, Anaïs Potron, Samuel Venner, Xavier Charpentier, Maria-Halima Laaberki

Erratum issuedAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Bovine-DerivedMicroorganisms · 2026
    Article
  6. Bacteria as living biosensors for DNA.Nature reviews bioengineering · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Large DNA fragment ISEc9-mediated transposition during natural transformation allows interspecies dissemination of antimicrobial resistance genes.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  11. Molecular Detection ofMicroorganisms · 2025
    Article
  12. Phenotypic and genetic heterogeneity ofMicrobial genomics · 2025
    Article
  13. Review
  14. The Evolution of Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Insights intoInternational journal of molecular sciences · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Anne-Sophie GodeuxCentre International de Recherche en Infectiologie (CIRI), INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Université de Lyon, Villeurbanne, France.
Elin Svedholm *Centre International de Recherche en Infectiologie (CIRI), INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Université de Lyon, Villeurbanne, France.
Samuel Barreto *UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive (LBBE), Université Claude Bernard Lyon 1, Villeurbanne, France.
Anaïs PotronFrench National Reference Center for Antibiotic Resistance, University Hospital of Besançon, Besançon, France.ORCID 0000-0002-2966-7947
Samuel VennerUMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive (LBBE), Université Claude Bernard Lyon 1, Villeurbanne, France.
Xavier Charpentier *Centre International de Recherche en Infectiologie (CIRI), INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Université de Lyon, Villeurbanne, France.ORCID 0000-0001-9039-8021
Maria-Halima Laaberki *Centre International de Recherche en Infectiologie (CIRI), INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Université de Lyon, Villeurbanne, France.ORCID 0000-0001-5796-5995

Funding

Agence Nationale de la Recherche (ANR) ANR-11-IDEX-0007Agence Nationale de la Recherche (ANR) ANR-11-LABX-0048VetAgro Sup (VetAgro-Sup) PhD funding VetAgro Sup
6 · The paper itself

Abstract

Acinetobacter baumannii infection poses a major health threat, with recurrent treatment failure due to antibiotic resistance, notably to carbapenems. While genomic analyses of clinical strains indicate that homologous recombination plays a major role in the acquisition of antibiotic resistance genes, the underlying mechanisms of horizontal gene transfer often remain speculative. Our understanding of the acquisition of antibiotic resistance is hampered by the lack of experimental systems able to reproduce genomic observations. We here report the detection of recombination events occurring spontaneously in mixed bacterial populations and which can result in the acquisition of resistance to carbapenems. We show that natural transformation is the main driver of intrastrain but also interstrain recombination events between A. baumannii clinical isolates and pathogenic species of Acinetobacter. We observed that interbacterial natural transformation in mixed populations is more efficient at promoting the acquisition of large resistance islands (AbaR4 and AbaR1) than when the same bacteria are supplied with large amounts of purified genomic DNA. Importantly, analysis of the genomes of the recombinant progeny revealed large recombination tracts (from 13 to 123 kb) similar to those observed in the genomes of clinical isolates. Moreover, we highlight that transforming DNA availability is a key determinant of the rate of recombinants and results from both spontaneous release and interbacterial predatory behavior. In the light of our results, natural transformation should be considered a leading mechanism of genome recombination and horizontal gene transfer of antibiotic resistance genes in Acinetobacter baumannii.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnimalsAnti-Bacterial AgentsCarbapenemsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsAnti-Bacterial AgentsCarbapenemsAbaRAcinetobacter baumanniiantibiotic resistancecarbapenem resistancehorizontal gene transfernatural transformationOXA23resistance islandtype VI secretion system

Identifiers

PMID35073754
PMCPMC8787482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.